Tag: Lord Greaves

The below Parliamentary question was asked by Lord Greaves on 2015-01-14.

To ask Her Majesty’s Government what information, advice and training is provided to doctors and nurses on the symptoms and treatment of Lyme disease; what advice is provided to general practitioners on the reference to specialists of patients exhibiting symptoms of Lyme disease; and which centres provide specialist treatment for that disease.

Baroness Jolly

Public Health England (PHE) and the National Health Service have detailed information on the recognition, diagnosis, treatment and management of Lyme disease. PHE has also written a guide on how to refer patients for specialist advice, which is attached. The National Institute for Health and Care Excellence also has an online guide for general practitioners (GP) and other health professionals.

PHE issues a letter to all GPs on an annual basis at the beginning of the tick season describing Lyme disease and highlighting the need to be aware and to recognise the condition. The majority of cases are managed by GPs without reference to specialists, but problem cases can be referred to neurology, rheumatology, cardiology and infectious disease clinics depending on the local provision and of services and patient’s symptoms. In addition to the attached guidance, Suggested referral pathway for patients with symptoms related to Lyme disease, PHE offers a telephone helpline for GPs and consultants to discuss particular cases. PHE works closely with the patient group Lyme Disease Action, who will also represent individuals who have trouble obtaining specialist advice, and can thus help in suggesting potential routes of referral.

The below Parliamentary question was asked by Lord Greaves on 2015-01-14.

To ask Her Majesty’s Government what assessment they have made of the quality and availability of tests for Lyme disease and related diseases in (1) the United Kingdom, (2) the rest of the European Union, and (3) North America.

Earl Howe

Public Health England (PHE) actively reviews test methodologies for Lyme disease based on peer reviewed reports and on evaluation of possible alternative test kits within the laboratory. As part of this work, staff from the Rare and Imported Pathogens Laboratory (RIPL) have attended international conferences, including those organised by pressure groups proposing alternative testing systems to those used in state laboratories, and met with private and state laboratory service providers in Europe and the United States.

RIPL offers a telephone advice line to clinicians with problem cases, and also works with the patient charity Lyme Disease Action to address the needs of individual patients. RIPL also participates in a European external quality assessment programme, and cross-compares results with Raigmore Hospital in Scotland.

All diagnostic tests for infectious diseases are less sensitive in the very early stages of disease, and the results of a laboratory test have to be interpreted in this light and in conjunction with the patient’s presentation. Whilst the current tests are not perfect, none of the alternatives have yet proven superior to accepted methodologies. Any novel methods to test for Lyme disease are kept under review.